Jialiang Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jialiang Zhang has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Fang-Yang Huang
Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital Sichuan University Chengdu People's Republic of China
4 shared publications - Mao Chen
Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China
4 shared publications - Wenhua Lei
Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital Sichuan University Chengdu People's Republic of China
4 shared publications - Yaoyu Zhang
Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital Sichuan University Chengdu People's Republic of China
3 shared publications Bo Su
2 shared publicationsFei Xu
2 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Wiley in Aging Cell
- Vol. 25 (11)
The Senokine Gas6 Promotes Aortic Valve Calcification Through CaMKII–DRP1–Mediated Terminal Scission of Mitochondrial‐Derived Vesicles
Calcific aortic valve disease (CAVD) is an age‐associated valvular disorder in which calcification expands from discrete foci into adjacent tissue. We investigated whether mitochondrial‐derived vesicles (MDVs) released by human valvular interstitial cells (hVICs) exert pro‐calcific effects on recipient cells and how MDV release is regulated. Using ex vivo hemodynamic perfusion of human CAVD tissue, multi‐omics profiling, live‐cell single‐organelle tracking, MDV transfer assays, and in vivo Gas6 deletion, we found that calcifying hVICs hypersecreted MDVs that exerted pro‐calcific effects in recipient hVICs. High‐resolution imaging showed that mitochondria remodeled into donut‐shaped structures under pro‐osteogenic conditions; these structures served as physical platforms for MDV budding. Human CAVD valve tissues and hVICs treated with pro‐osteogenic medium also exhibited senescence‐associated features. Multi‐omics profiling identified growth arrest‐specific 6 (Gas6), a senokine, among 36 concordantly upregulated candidates. Functional analyzes showed that Gas6 promoted terminal MDV scission while leaving donut‐shaped mitochondrial precursor formation intact. Mechanistically, Gas6 promoted intracellular Ca 2+ accumulation, calcium/calmodulin‐dependent protein kinase II (CaMKII) activation, and dynamin‐related protein 1 (DRP1) phosphorylation at Ser616, supporting a Ca 2+ –CaMKII–DRP1 axis that facilitates terminal MDV scission. Pharmacological inhibition of CaMKII or DRP1 reduced MDV hypersecretion and subsequent recipient‐cell calcification, and Gas6 deletion in vivo attenuated valvular stenosis, calcification, and fibrotic remodeling. These findings identify Gas6‐dependent terminal MDV scission as a mechanism contributing to the intercellular propagation of valvular calcification in a CAVD context characterized by senescence‐associated features.
- 20 October 2026
- Published by Wiley in Aging Cell
- Vol. 25 (11)
Open AccessThe Senokine Gas6 Promotes Aortic Valve Calcification Through CaMKII–DRP1–Mediated Terminal Scission of Mitochondrial‐Derived Vesicles
Calcific aortic valve disease (CAVD) is an age‐associated valvular disorder in which calcification expands from discrete foci into adjacent tissue. We investigated whether mitochondrial‐derived vesicles (MDVs) released by human valvular interstitial cells (hVICs) exert pro‐calcific effects on recipient cells and how MDV release is regulated. Using ex vivo hemodynamic perfusion of human CAVD tissue, multi‐omics profiling, live‐cell single‐organelle tracking, MDV transfer assays, and in vivo Gas6 deletion, we found that calcifying hVICs hypersecreted MDVs that exerted pro‐calcific effects in recipient hVICs. High‐resolution imaging showed that mitochondria remodeled into donut‐shaped structures under pro‐osteogenic conditions; these structures served as physical platforms for MDV budding. Human CAVD valve tissues and hVICs treated with pro‐osteogenic medium also exhibited senescence‐associated features. Multi‐omics profiling identified growth arrest‐specific 6 (Gas6), a senokine, among 36 concordantly upregulated candidates. Functional analyzes showed that Gas6 promoted terminal MDV scission while leaving donut‐shaped mitochondrial precursor formation intact. Mechanistically, Gas6 promoted intracellular Ca 2+ accumulation, calcium/calmodulin‐dependent protein kinase II (CaMKII) activation, and dynamin‐related protein 1 (DRP1) phosphorylation at Ser616, supporting a Ca 2+ –CaMKII–DRP1 axis that facilitates terminal MDV scission. Pharmacological inhibition of CaMKII or DRP1 reduced MDV hypersecretion and subsequent recipient‐cell calcification, and Gas6 deletion in vivo attenuated valvular stenosis, calcification, and fibrotic remodeling. These findings identify Gas6‐dependent terminal MDV scission as a mechanism contributing to the intercellular propagation of valvular calcification in a CAVD context characterized by senescence‐associated features.
- 18 March 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (6) , e70437
Uric acid promotes aortic valve calcification via mediating valve interstitial cell osteogenic differentiation and endothelial dysfunction
Aortic valve calcification is a lethal valvular heart disease lacking effective drug therapy. However, whether uric acid is involved in the development of aortic valve calcification is unclear. Two‐sample Mendelian randomization (MR) analyses confirmed the causal relationship between uric acid and valvular heart disease. Uric acid levels were assessed in aortic valve tissue from patients with/without aortic valve calcification. To investigate the impact of hyperuricemia on aortic valve calcification, apolipoprotein E knockout (ApoE −/− ) mice fed a high‐fat diet (HFD) were also given an adenine diet, with some receiving allopurinol in their drinking water. RNA sequencing was performed on valve interstitial cells (VICs) and endothelial cells (VECs) with/without uric acid. MR analysis has revealed a causal effect of uric acid levels on valvular heart disease. Furthermore, our clinical data indicate a positive correlation between elevated serum uric acid levels and aortic valve calcium score. Specifically, uric acid levels were upregulated in calcified valves. In ApoE −/− mice, an adenine‐diet‐induced hyperuricemia accelerated aortic valve calcification. RNA sequencing analysis demonstrated that uric acid‐promoted osteogenic differentiation, primarily through the activation of hypoxia‐inducible factor‐1alpha (HIF‐α). Additionally, uric acid impaired endothelial barrier function by activating HIF‐α, resulting in increased macrophage infiltration in ApoE −/− mice. Inhibiting HIF‐1α suppressed osteogenic differentiation and reduced endothelial injury both in vitro and in vivo in the presence of uric acid. This study reveals a new role of hyperuricemia in aortic valve calcification, suggesting uric acid‐lowering drugs or HIF‐1α inhibition as potential treatments for associated aortic valve calcification.
- 18 March 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (6) , e70437
Uric acid promotes aortic valve calcification via mediating valve interstitial cell osteogenic differentiation and endothelial dysfunction
Aortic valve calcification is a lethal valvular heart disease lacking effective drug therapy. However, whether uric acid is involved in the development of aortic valve calcification is unclear. Two‐sample Mendelian randomization (MR) analyses confirmed the causal relationship between uric acid and valvular heart disease. Uric acid levels were assessed in aortic valve tissue from patients with/without aortic valve calcification. To investigate the impact of hyperuricemia on aortic valve calcification, apolipoprotein E knockout (ApoE −/− ) mice fed a high‐fat diet (HFD) were also given an adenine diet, with some receiving allopurinol in their drinking water. RNA sequencing was performed on valve interstitial cells (VICs) and endothelial cells (VECs) with/without uric acid. MR analysis has revealed a causal effect of uric acid levels on valvular heart disease. Furthermore, our clinical data indicate a positive correlation between elevated serum uric acid levels and aortic valve calcium score. Specifically, uric acid levels were upregulated in calcified valves. In ApoE −/− mice, an adenine‐diet‐induced hyperuricemia accelerated aortic valve calcification. RNA sequencing analysis demonstrated that uric acid‐promoted osteogenic differentiation, primarily through the activation of hypoxia‐inducible factor‐1alpha (HIF‐α). Additionally, uric acid impaired endothelial barrier function by activating HIF‐α, resulting in increased macrophage infiltration in ApoE −/− mice. Inhibiting HIF‐1α suppressed osteogenic differentiation and reduced endothelial injury both in vitro and in vivo in the presence of uric acid. This study reveals a new role of hyperuricemia in aortic valve calcification, suggesting uric acid‐lowering drugs or HIF‐1α inhibition as potential treatments for associated aortic valve calcification.
- Open Access
- 15 November 2021
- Published by Springer Nature in Research Square
Resolvin D1 inhibits endothelial permeability and mitochondrial damage following cardiac ischemia reperfusion in diabetic mice
Purpose Novel strategies for preventing myocardial ischemia reperfusion injury (MIRI) in a diabetic heart are urgently needed. Resolvin D1 (RvD1) plays important therapeutic roles in inflammatory diseases. However, the therapeutic role of RvD1 in diabetic MIRI is still unknown. Methods Diabetic mice were established with a high-fat diet and streptozotocin (STZ). The mice were pretreated with RvD1 via intraperitoneal injection for 3 days, followed by MIRI. To evaluate the effects of RvD1 on chronic cardiac remodelling, RvD1 was administered for another 2 weeks after MIRI. The effects of RvD1 following MIRI were measured, including the severity of infarct size, regional inflammation, cardiac function, and permeability of cultured endothelial monolayers. Mitochondrial reactive oxygen species (MitoROS) and mitochondrial membrane potential (MMP) were determined using MitoSOX and JC-1. Results RvD1 pretreatment significantly reduced infarct size and the Evans blue content in diabetic injured hearts, which was associated with improved endothelial permeability. At 2 weeks after MIRI, RvD1 treatment partially improved cardiac performance and reduced cardiac fibrosis in diabetic MIRI mice. In vitro, RvD1 attenuated endothelial leakage induced by hypoxia-reoxygenation, H2O2, and lipopolysaccharide (LPS) under high glucose (HG) conditions. Meanwhile, RvD1 remarkably protected endothelial cells from H2O2-induced mitochondrial damage, as evidenced by increased MMP and decreased MitoROS, which was associated with the preservation of VE-cadherin. Conclusion RvD1 alleviates MIRI-induced endothelial permeability and mitochondrial damage injuries in diabetic hearts. Therefore, RvD1 could be a potential therapeutic target for MIRI in diabetes.
- 15 November 2021
- Published by Springer Nature in Research Square
Open AccessResolvin D1 inhibits endothelial permeability and mitochondrial damage following cardiac ischemia reperfusion in diabetic mice
Purpose Novel strategies for preventing myocardial ischemia reperfusion injury (MIRI) in a diabetic heart are urgently needed. Resolvin D1 (RvD1) plays important therapeutic roles in inflammatory diseases. However, the therapeutic role of RvD1 in diabetic MIRI is still unknown. Methods Diabetic mice were established with a high-fat diet and streptozotocin (STZ). The mice were pretreated with RvD1 via intraperitoneal injection for 3 days, followed by MIRI. To evaluate the effects of RvD1 on chronic cardiac remodelling, RvD1 was administered for another 2 weeks after MIRI. The effects of RvD1 following MIRI were measured, including the severity of infarct size, regional inflammation, cardiac function, and permeability of cultured endothelial monolayers. Mitochondrial reactive oxygen species (MitoROS) and mitochondrial membrane potential (MMP) were determined using MitoSOX and JC-1. Results RvD1 pretreatment significantly reduced infarct size and the Evans blue content in diabetic injured hearts, which was associated with improved endothelial permeability. At 2 weeks after MIRI, RvD1 treatment partially improved cardiac performance and reduced cardiac fibrosis in diabetic MIRI mice. In vitro, RvD1 attenuated endothelial leakage induced by hypoxia-reoxygenation, H2O2, and lipopolysaccharide (LPS) under high glucose (HG) conditions. Meanwhile, RvD1 remarkably protected endothelial cells from H2O2-induced mitochondrial damage, as evidenced by increased MMP and decreased MitoROS, which was associated with the preservation of VE-cadherin. Conclusion RvD1 alleviates MIRI-induced endothelial permeability and mitochondrial damage injuries in diabetic hearts. Therefore, RvD1 could be a potential therapeutic target for MIRI in diabetes.
- Open Access
- 5 June 2021
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 2021, 1-10
Sodium Lactate Accelerates M2 Macrophage Polarization and Improves Cardiac Function after Myocardial Infarction in Mice
Background. After myocardial infarction, anti-inflammatory macrophages perform key homeostatic functions that facilitate cardiac recovery and remodeling. Several studies have shown that lactate may serve as a modifier that influences phenotype of macrophage. However, the therapeutic role of sodium lactate in myocardial infarction (MI) is unclear. Methods. MI was established by permanent ligation of the left anterior descending coronary artery followed by injection of saline or sodium lactate. Cardiac function was assessed by echocardiography. The cardiac fibrosis area was assessed by Masson trichrome staining. Macrophage phenotype was detected via qPCR, flow cytometry, and immunofluorescence. Signaling proteins were measured by Western blotting. Results. Sodium lactate treatment following MI improved cardiac performance, enhanced anti-inflammatory macrophage proportion, reduced cardiac myocytes apoptosis, and increased neovascularization. Flow-cytometric analysis results reported that sodium lactate repressed the number of the IL-6+, IL-12+, and TNF-α+ macrophages among LPS-stimulated bone marrow-derived macrophages (BMDMs) and increased the mRNA levels of Arg-1, YM1, TGF-β, and IL-10. Mechanistic studies revealed that sodium lactate enhanced the expression of P-STAT3. Furthermore, a STAT3 inhibitor eliminated sodium lactate-mediated promotion macrophage polarization. Conclusion. Sodium lactate facilitates anti-inflammatory M2 macrophage polarization and protects against MI by regulating P-STAT3.
- 5 June 2021
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 2021, 1-10
Open AccessSodium Lactate Accelerates M2 Macrophage Polarization and Improves Cardiac Function after Myocardial Infarction in Mice
Background. After myocardial infarction, anti-inflammatory macrophages perform key homeostatic functions that facilitate cardiac recovery and remodeling. Several studies have shown that lactate may serve as a modifier that influences phenotype of macrophage. However, the therapeutic role of sodium lactate in myocardial infarction (MI) is unclear. Methods. MI was established by permanent ligation of the left anterior descending coronary artery followed by injection of saline or sodium lactate. Cardiac function was assessed by echocardiography. The cardiac fibrosis area was assessed by Masson trichrome staining. Macrophage phenotype was detected via qPCR, flow cytometry, and immunofluorescence. Signaling proteins were measured by Western blotting. Results. Sodium lactate treatment following MI improved cardiac performance, enhanced anti-inflammatory macrophage proportion, reduced cardiac myocytes apoptosis, and increased neovascularization. Flow-cytometric analysis results reported that sodium lactate repressed the number of the IL-6+, IL-12+, and TNF-α+ macrophages among LPS-stimulated bone marrow-derived macrophages (BMDMs) and increased the mRNA levels of Arg-1, YM1, TGF-β, and IL-10. Mechanistic studies revealed that sodium lactate enhanced the expression of P-STAT3. Furthermore, a STAT3 inhibitor eliminated sodium lactate-mediated promotion macrophage polarization. Conclusion. Sodium lactate facilitates anti-inflammatory M2 macrophage polarization and protects against MI by regulating P-STAT3.
- Open Access
- 1 January 2016
- Published by Shanghai Institute of Ceramics in Journal of Inorganic Materials
- Vol. 31 (8) , 850-854
Physical Properties of Ba(Ti$lt;inf$gt;0.96$lt;/inf$gt;Sn$lt;inf$gt;0.04$lt;/inf$gt;)O$lt;inf$gt;3$lt;/inf$gt; Ceramics
Ba(Ti 0.96 Sn 0.04)O 3 陶瓷的物性研究 武燕庆, 张家良, 刘大康, 孙丹丹 (山东大学 物理学院, 晶体材料国家重点实验室, 济南 250100) 摘 要: 采用传统固相反应法制备了 Ba(Ti 0.96 Sn 0.04)O 3 无铅压电陶瓷, 对其压电性能、介电性能、铁电性能和微观结 构等进行了研究。研究发现, 原料以及制备工艺对 Ba(Ti 0.96 Sn 0.04)O 3 陶瓷的压电性质具有较大的影响。与 BaTiO 3 陶瓷相比, Ba(Ti 0.96 Sn 0.04)O 3 陶瓷的正交-四方相变温度 T O-T 得到了一定的提高, 并且 T O-T 附近的热滞只有 1.8℃。 陶瓷的微观形貌呈现出较为复杂的畴结构, 主要以 90°平行带状畴为主, 偶尔有少量不同构型的 180°畴。电滞回线 呈现为理想的近似矩形饱和形状的曲线, 剩余极化强度 P r 为 18.9 μC/cm 2 , 矫顽场 E c 为 2
- 1 January 2016
- Published by Shanghai Institute of Ceramics in Journal of Inorganic Materials
- Vol. 31 (8) , 850-854
Open AccessPhysical Properties of Ba(Ti$lt;inf$gt;0.96$lt;/inf$gt;Sn$lt;inf$gt;0.04$lt;/inf$gt;)O$lt;inf$gt;3$lt;/inf$gt; Ceramics
Ba(Ti 0.96 Sn 0.04)O 3 陶瓷的物性研究 武燕庆, 张家良, 刘大康, 孙丹丹 (山东大学 物理学院, 晶体材料国家重点实验室, 济南 250100) 摘 要: 采用传统固相反应法制备了 Ba(Ti 0.96 Sn 0.04)O 3 无铅压电陶瓷, 对其压电性能、介电性能、铁电性能和微观结 构等进行了研究。研究发现, 原料以及制备工艺对 Ba(Ti 0.96 Sn 0.04)O 3 陶瓷的压电性质具有较大的影响。与 BaTiO 3 陶瓷相比, Ba(Ti 0.96 Sn 0.04)O 3 陶瓷的正交-四方相变温度 T O-T 得到了一定的提高, 并且 T O-T 附近的热滞只有 1.8℃。 陶瓷的微观形貌呈现出较为复杂的畴结构, 主要以 90°平行带状畴为主, 偶尔有少量不同构型的 180°畴。电滞回线 呈现为理想的近似矩形饱和形状的曲线, 剩余极化强度 P r 为 18.9 μC/cm 2 , 矫顽场 E c 为 2